in this article, we survey the asymptotic stability analysis of fractional differential systems with the prabhakar fractional derivatives. we present the stability regions for these types of fractional differential systems. a brief comparison with the stability aspects of fractional differential systems in the sense of riemann-liouville fractional derivatives is also given.

in this paper, boundary value problems of fractional order are converted into an optimal control problems. then an approximate solution is constructed from translations and dilations of a b-spline function such that the exact boundary conditions are satisfied. the fractional differential operators are taken in the riemann-liouville and caputo sense. several example are given and the optimal err...

BURNEXT,JOHNC., JR., JOEY P.GRANGER, AND TERRY J. OPGENORTH. Effects of synthetic atrid nutriuretic factor on renal function and renin release. Am. J. Physiol. 247 (Renal Fluid Electrolyte Physiol. 16): F863-F866,1984.-Studies were performed in anesthetized dogs (n = 5) to determine the effects of synthetic atrial natriuretic factor on renal function and renin release. Intrarenal infusion of sy...

BACKGROUND Fractional photothermolysis has become an important laser modality in management of a number of skin conditions and photoaging. The authors describe the scientific basis of fractional photothermolysis, report on most of the available devices, discuss their clinical uses and techniques, and attempt to decipher their relative efficacy. METHODS The authors reviewed as best as possible...

Resting sarcoplasmic reticulum (SR) Ca content ([CaSR]R) was varied in cut fibers equilibrated with an internal solution that contained 20 mM EGTA and 0-1.76 mM Ca. SR Ca release and [CaSR]R were measured with the EGTA-phenol red method (. J. Gen. Physiol. 106:259-336). After an action potential, the fractional amount of Ca released from the SR increased from 0.17 to 0.50 when [CaSR]R was reduc...

Objective: Febuxostat, a xanthine oxidoreductase inhibitor, is a drug of choice for hyperuricemia and Gout. But it also suffers from drawbacks in terms of pharmacokinetic profile and toxicity. It is available as immediate release formulation in the market. The objective is to develop a modified release formulation of febuxostat that can serve the dual purpose of increasing the efficacy and decr...